Pharmacy Pearls Information

All Pharmacy Pearls

January 5th, 2021 | Pharmacy PearlsMigraine

This edition of Pharmacy Pearls reviews the new agents that have been approved for acute migraine treatment and covers important clinical information including mechanism of action, efficacy data, common drug interactions, and cost. As most available clinical trials compare these agents to placebo (not currently available therapies), we also review potential role in therapy for…

Read More ›

November 24th, 2020 | Pharmacy PearlsCardiology

This edition of Pharmacy Pearls offers a review of therapies for anticoagulation: including how to determine whether warfarin or direct oral anticoagulants (DOACs) might be the most appropriate choice for a patient, how to select which DOAC to prescribe for specific patient populations, different dosing strategies based on indication and renal function, and how to…

Read More ›

August 31st, 2020 | Pharmacy PearlsDiabetes

This edition of Pharmacy Pearls focuses on using low-dose aspirin for ASCVD prevention. We highlight when aspirin is indicated to reduce ASCVD risk, as well as when it might be appropriate to de-prescribe (stop) based on patient-specific criteria. An algorithm is included that providers can follow to determine whether their patients are eligible for low-dose…

Read More ›

June 29th, 2020 | Pharmacy PearlsDiabetes

This edition of Pharmacy Pearls compares the CV outcome study characteristics and results for both the glucagon-like peptide-1 receptor agonist (GLP-1 RA) and sodium glucose cotransporter 2 (SGLT2) inhibitor classes of medications.  It also summarizes key points in regard to the newer oral GLP-1 RA, Rybelsus®, as well as a listing of expanded indications for…

Read More ›

June 16th, 2020 | Pharmacy PearlsCardiology

This edition of Pharmacy Pearls reviews the benefits of utilizing generic statins for treatment of hyperlipidemia, as certain brand-name statins can reach almost $900 per month. Generic statins have an abundance of safety and efficacy data to support their use, and some can be utilized on alternate dosing schedules for patients who have tolerance issues….

Read More ›

May 27th, 2020 | Asthma/COPDPharmacy Pearls

In the following edition of Pharmacy Pearls, the AHP Pharmacy Team has reviewed and presents the 2020 GOLD guidelines for COPD management, focusing on medication therapy. There is also information regarding the most commonly used/well-covered inhalers for COPD, including those that offer generic versions. As always, we welcome any feedback or questions you may have….

Read More ›

May 8th, 2020 | Pharmacy PearlsInfectious Diseases

This edition of Pharmacy Pearls reviews medication management of asthma- in children, adults, and how management is affected by the COVID-19 pandemic. You will also find inhaler device technique steps and tips for assessing a patient’s asthma. As always, we welcome any feedback or questions you may have. Just email the Pharmacy Team. Click here…

Read More ›

May 8th, 2020 | Asthma/COPDPharmacy Pearls

This edition of Pharmacy Pearls reviews medication management of asthma- in children, adults, and how management is affected by the COVID-19 pandemic. You will also find inhaler device technique steps and tips for assessing a patient’s asthma. As always, we welcome any feedback or questions you may have. Just email the Pharmacy Team. Click here…

Read More ›

May 8th, 2020 | Asthma/COPDPharmacy Pearls

This edition of Pharmacy Pearls reviews medication management of asthma- in children, adults, and how management is affected by the COVID-19 pandemic. You will also find inhaler device technique steps and tips for assessing a patient’s asthma. As always, we welcome any feedback or questions you may have. Just email the Pharmacy Team. Click here…

Read More ›

March 31st, 2020 | Pharmacy PearlsInfectious Diseases

Click the link here to download a PDF of COVID-19 Pharmacy Pearls.

March 29th, 2020 | Pharmacy PearlsInfectious Diseases
March 3rd, 2020 | Asthma/COPDPharmacy Pearls

In this edition of Pharmacy Pearls, we have updated our inhaler chart to include a new generic ICS/LABA that has come to market. Budesonide/formoterol, an authorized generic of Symbicort, is now available for prescribers to order. At this time, it does not represent a significant cost savings for the network compared to other available generic…

Read More ›

February 5th, 2020 | Pharmacy PearlsCardiology

This edition of Pharmacy Pearls critically reviews the data of the REDUCE-IT trial for Vascepa, which resulted in its new FDA-labeled indication for cardiovascular risk reduction with mild hypertriglyceridemia. We have also included an algorithm for how to address statin-associated muscle symptoms (SAMS). As always, we welcome any questions or feedback you may have. Just…

Read More ›

January 24th, 2020 | Pharmacy PearlsInfectious Diseases

According to the CDC, Influenza B/Victoria viruses are predominant nationally, which is unusual for this time of year. H1N1 viruses are the next most common. H3N2 and B/Yamagata viruses are circulating at very low levels. In NYS, influenza is currently categorized as widespread with similar frequency patterns of viral types and subtypes. Influenza appears to…

Read More ›

December 18th, 2019 | DepressionBehavioral HealthPharmacy Pearls

This edition of Pharmacy Pearls provides a depression management algorithm for adult and pediatric (age 12+) patients that was developed in collaboration with AHP’s Behavioral Health Integration Team. In these documents below you will find AHP-endorsed depression management principles including: management based on depression severity, guidance for initiation of new antidepressant therapy (focusing on SSRIs)…

Read More ›

November 22nd, 2019 | Pharmacy PearlsDiabetes

This edition of Pharmacy Pearls gives an overview of best practices for management of type 2 diabetes. In it you will find AHP endorsed principles for the management of type 2 diabetes adapted from the 2019 ADA Standards of Care in Diabetes and the MCMS Diabetes Guidelines. The AHP Pharmacy Team would like to thank…

Read More ›

November 11th, 2019 | Pharmacy PearlsDiabetes

This edition of Pharmacy Pearls gives an overview of insulin lispro U-100, the new authorized generic for Humalog U-100, which is now available. Insulin lispro U-100 is considered therapeutically equivalent to the brand name because it is exactly the same drug. It is available at approximately half the cost of brand name Humalog U-100. Your…

Read More ›

September 30th, 2019 | Medication AccessPharmacy Pearls

With one in four patients reporting difficulty affording prescription medications, practice staff and clinicians are often engaged with patients faced with mediation access issues related to cost and affordability. The AHP Pharmacy team has created a tool for practices to use that includes an algorithm to identify strategies to help resolve cost issues by insurance…

Read More ›

August 28th, 2019 | HyperlipidemiaPharmacy PearlsCardiology

This edition of Pharmacy Pearls gives an overview of the recent updates made to the ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. This guideline (last updated in 2013) focuses on primary prevention in adults to reduce the risk of ASCVD (acute coronary syndromes, myocardial infarction, stable or unstable angina, arterial revascularization, stroke/transient ischemic…

Read More ›

July 12th, 2019 | AllergyPharmacy Pearls

This edition of Pharmacy Pearls reviews the available epinephrine injector options for the treatment of anaphylaxis. There are several devices available (both brand and generic), and the cost to patients can vary greatly. In addition to information regarding differences in the devices and an update on the nationwide shortage of brand EpiPen, the take away…

Read More ›

June 24th, 2019 | Asthma/COPDPharmacy Pearls

This edition of Pharmacy Pearls highlights the availability of several generic maintenance inhalers now on the market and how to ensure patients get the least expensive formulation at the pharmacy. The goal is to increase patient access to these inhalers, so we encourage the use of the generics whenever possible and Symbicort when the generics…

Read More ›

May 9th, 2019 | AllergyPharmacy Pearls

One of the 2019 AHP Pharmacy Team targets is to limit the use of Nasonex for allergic rhinitis given the availability of equally effective and far less expensive OTC products, such as fluticasone propionate. Given that allergy season is upon us, this Pharmacy Pearls presents a primer to the treatment of allergic rhinitis with information…

Read More ›

February 19th, 2019 | Pharmacy PearlsDiabetes

The AHP Pharmacy Task Force works to identify opportunities that will enhance the quality, safety and value of medication treatment for our patients. Recently, we identified a cohort of patients across the PCN on duplicate therapy for Type 2 Diabetes with a GLP-1 agonist (e.g., Victoza, Trulicity, Byetta, Bydureon) and a DPP-4 inhibitor (e.g., Januvia,…

Read More ›

November 13th, 2018 | Pharmacy PearlsInfectious Diseases

As a reminder, November 12-18, 2018 is U.S. Antibiotic Awareness Week. The CDC is urging healthcare professionals to prescribe antibiotics only when necessary to help fight antibiotic resistance and protect patients from adverse events. During U.S. Antibiotic Awareness Week the CDC promotes Be Antibiotics Aware, an educational effort to raise awareness about the importance of…

Read More ›

April 2nd, 2018 | Pharmacy Pearls

As discussed in the last Pharmacy Pearls “Less Expensive Inhaler Now Available,” switching patients to RespiClick will help AHP realize significant savings as well as help patients with their out-of-pocket costs. The patient education handout below can be provided to patients making the switch to ensure that they use their new inhaler correctly.

April 2nd, 2018 | Asthma/COPDPharmacy Pearls

As discussed in the last Pharmacy Pearls “Less Expensive Inhaler Now Available,” switching patients to RespiClick will help AHP realize significant savings as well as help patients with their out-of-pocket costs. The patient education handout below can be provided to patients making the switch to ensure that they use their new inhaler correctly.

December 8th, 2016 | Pharmacy PearlsGERD

By Matt Devine, D.O. With all of the holiday food that we are preparing, this discussion is meant to inform all of us on our PPI therapy use. From review of our network’s Excellus commercial pharmacy data, we have confirmed that, like many systems around the country, we have a lot of adult patients in…

Read More ›

September 14th, 2016 | Pharmacy PearlsGERD
May 31st, 2016 | Pharmacy PearlsGERD

Welcome to the first installment of the Pharmacy Pearls newsletter. This edition discusses the evidence behind some recently raised concerns surrounding PPI use along with guidance for tapering to minimize rebound hypersecretion. We hope you find this useful in your daily practice. Suggestions or comments may be directed to Jineane Venci, clinical pharmacist at [email protected]